OGEN stock news

TAMPA, Fla.--(BUSINESS WIRE)--Oragenics Inc. to Present at the LD Micro 12th Annual Main Event on December 10, 2019 Read more
TAMPA, Fla.--(BUSINESS WIRE)--Oragenics, Inc Publishes Study in Journal of Peptide Science Demonstrating First Complete Chemical Synthesis of Bicyclic Ring of a Mutacin 1140 Analog Read more
TAMPA, Fla.--(BUSINESS WIRE)--MARTIN HANDFIELD, PH.D. TO BE FEATURED SPEAKER AT THE INTERNATIONAL CONFERENCE ON MICROBIAL RESEARCH AND APPLICATIONS Read more
It is not uncommon to see companies perform well in the years after insiders buy shares. On the other hand, we'd be… Read more
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Aug. 14) GENMAB A/S/S ADR (NASDAQ: GMAB ) (announced first-half results and raised 2019 guidance) Down In The Dumps (Biotech stocks hitting 52-week lows on Aug. 14) Acer Therapeutics Inc (NASDAQ: ACER ) (reacted to second-quarter results) Acorda Therapeutics Inc (NASDAQ: ACOR ) Adaptimmune Therapeutics PLC – ADR (NASDAQ: ADAP ) Akorn, Inc. (NASDAQ: AKRX ) Amneal Pharmaceuticals Inc (NYSE: AMRX ) aTyr Pharma Inc (NASDAQ: LIFE ) (reacted to second-quarter results) Bicycle Therapeutics PLC (NASDAQ: BCYC ) BioMarin Pharmaceutical Inc. (NASDAQ: BMRN ) Cancer Genetics Inc (NASDAQ: CGIX ) Cellectis SA (NASDAQ: CLLS ) DelMar Pharmaceuticals Inc (NASDAQ: DMPI )(announced $6.5 million common stock offering) DiaMedica Therapeutics Inc (NASDAQ: DMAC )(reacted to second-quarter results) Ekso Bionics Holdings Inc (NASDAQ: EKSO ) Fulcrum Therapeutics Inc (NASDAQ: FULC ) GENFIT S A/ADR (NASDAQ: GNFT ) Kiniksa Pharmaceuticals Ltd (NASDAQ: KNSA ) Medigus ADR (NASDAQ: MDGS ) Meridian Bioscience, Inc. Read more
Oragenics Inc. (NYSEAMERICAN:OGEN) and Strongbridge Biopharma plc (NASDAQ:SBBP) have been rivals in the Biotechnology for quite some time. Below is a review of each business including various aspects Read more
Interested investors might be taking a look at the medium range signals for Oragenics Inc (OGEN). The reading from the 40-day commodity channel index is currently Sell. The CCI indicator is mainly use Read more
Oragenics Inc (OGEN) are in focus as we look at near-term expected movement. The reading from the 40-day commodity channel index is currently Sell. The CCI indicator is mainly used to identify oversol Read more
Investors may be diving into the latest company earnings reports trying to scope out some quality stocks to add to the portfolio. Nobody knows for sure which way overall market momentum will sway as w Read more
Oragenics Inc. (NYSEAMERICAN:OGEN) and vTv Therapeutics Inc. (NASDAQ:VTVT), both competing one another are Biotechnology companies. We will contrast their analyst recommendations, profitability, insti Read more
As Biotechnology businesses, Oragenics Inc. (NYSEAMERICAN:OGEN) and Veracyte Inc. (NASDAQ:VCYT), are affected by compare. This especially applies to their risk, analyst recommendations, institutional Read more
Oragenics Inc. (NYSEAMERICAN:OGEN) and OncoCyte Corporation (NYSEAMERICAN:OCX) compete with each other in the Biotechnology sector. We will analyze and compare their profitability, analyst recommendat Read more
Oragenics Inc. (NYSEAMERICAN:OGEN) and Y-mAbs Therapeutics Inc. (NASDAQ:YMAB) compete with each other in the Biotechnology sector. We will analyze and contrast their profitability, institutional owner Read more
Oragenics Inc (OGEN) has ended the week in the red, yielding negative results for the shares at they ticked -4.84%. In taking a look at recent performance, we can see that shares have moved -33.13% ov Read more

Proudly made at

ROCKIT